InfraReDx to showcase the LipiScan™ Coronary Imaging System at the Cardiovascular Research Foundation’s (CRF) annual Transcatheter Cardiovascular Therapeutics (TCT) scientific meeting

Results of Initial Clinical Experience with a Novel Spectroscopy Catheter that can Identify Lipid-Core Coronary Plaques to be presented at TCT 2009

FOR IMMEDIATE RELEASE - September 11th  2009 –Burlington, MA

InfraReDx today announced its preliminary schedule of events at the Cardiovascular Research Foundation’s (CRF) annual Transcatheter Cardiovascular Therapeutics (TCT) scientific meeting, scheduled from Monday, September 21st to Friday, September 25th, in San Francisco, CA. at the Moscone Center. This scientific meeting is one of the world’s largest events for those performing cardiac diagnostics and interventions.

The LipiScan™ Coronary Imaging System will be displayed in the “Emerging Technologies” section at booth # 2410.   Schedule of InfraReDx Events at TCT 2009 are as follows:

Monday, September 21st

On behalf of Cardiovascular Research Foundation, Dr. James Muller, founder and CEO of InfraReDx, has been invited to participate as a guest speaker titled:

“Vulnerable Plaque: Emerging Directions for Diagnosis and Treatment: Near Infrared Spectroscopy I: Technology and validation.”

• 2:40 pm in room # 130 at the Moscone Center.

Friday, September 25th

InfraReDx sponsored Breakfast Symposium:

“Beyond Angiography:  NIR Spectroscopy and Other Methods for Plaque Characterization.”

• 6:30 am Breakfast, 7:00 am Symposium in room #120 at the Moscone Center. Presenters include: Dr. Cindy Grines (Beaumont Hospital), Dr. Gregg W. Stone (Presbyterian/Columbia), Dr. Emmanouil Brilakis (Dallas VA), Dr. Brijeshwar Maini (Moffitt Heart and Vascular), Dr. Patrick Serruys (Erasmus Medical Center), and Dr. James E. Muller (InfraReDx).

About InfraReDx, Inc.
InfraReDx, Inc., headquartered in Burlington, Massachusetts, was founded in 1998 and is a privately-funded medical device company developing a fiber-optic, catheter-based, near-infrared (NIR) spectroscopy system to identify and characterize vulnerable plaque in the coronary arteries. For more information, visit www.infraredx.com.

About TCT 2009
TCT is organized by the Cardiovascular Research Foundation, which is dedicated to research and education in the broad subspecialty of interventional cardiology and endovascular medicine. The TCT meeting is the primary annual meeting for the world-wide interventional cardiology community. For more information, visit www.tctconference.com

Company Contacts:

Dr. Muller Contact:                         Investor Contact:                             Media Contact:
Carolyn Rogers                                 Jeff Mazur                                            Jim Dillon
InfraReDx, Inc.                                 InfraReDx, Inc.                                 InfraReDx, Inc.
(781) 345-9644                                (781) 345-9626                                (781) 345-9679
crogers@infraredx.com                jmazur@infraredx.com                jdillon@infraredx.com